Search

Your search keyword '"ROULEAU, JEAN L."' showing total 1,219 results

Search Constraints

Start Over You searched for: Author "ROULEAU, JEAN L." Remove constraint Author: "ROULEAU, JEAN L."
1,219 results on '"ROULEAU, JEAN L."'

Search Results

1. Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9—Pragmatic Research and Innovation through Multinational Experimentation

2. Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF

3. Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF

8. Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial

14. Abstract 13828: Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARADIGM-HF Proteomic Sub-Study

15. Abstract 12701: Safety and Tolerability of Angiotensin Receptor Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Drug Initiation Setting: A Subgroup Analysis of the PARADISE-MI Trial

16. Abstract 12470: Sacubitril/Valsartan in Patients With Heart Failure and Deterioration of Kidney Function to Estimated Glomerular Filtration Rate Less Than 30ml/min/1.73m2: Insights From PARAGON-HF and PARADIGM-HF

17. Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy

18. Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction

22. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

24. Incidence and Outcomes of Pneumonia in Patients With Heart Failure

26. Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failure

27. Pulmonary Congestion and Left Ventricular Dysfunction after Myocardial Infarction:Insights from the PARADISE-MI Trial

29. High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT

30. Independent prognostic importance of blood urea nitrogen (BUN) to creatinine ratio in heart failure

31. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial

36. Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF.

37. Abstract 12470: Sacubitril/Valsartan in Patients With Heart Failure and Deterioration of Kidney Function to Estimated Glomerular Filtration Rate Less Than 30ml/min/1.73m 2 : Insights From PARAGON-HF and PARADIGM-HF

38. Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan

39. Calcium channel blocker and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction

44. Impact of Intubation Time on Survival following Coronary Artery Bypass Grafting: Insights from the Surgical Treatment for Ischemic Heart Failure (STICH) Trial

47. Knowledge about self‐efficacy and outcomes in patients with heart failure and reduced ejection fraction

48. Changes in mid‐regional pro‐adrenomedullin during treatment with sacubitril/valsartan

49. Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with HFrEF and HFpEF

50. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Catalog

Books, media, physical & digital resources